[Atherosclerosis and chronic persistent virus infection].

Area of Science:

• Virology
• Cardiovascular Medicine
• Epidemiology

Context:

• Atherosclerosis is a leading cause of cardiovascular disease globally.
• Chronic persistent infections are increasingly recognized as potential contributors to chronic diseases.
• The role of viral infections in the etiology of atherosclerosis requires further investigation.

Purpose:

• To investigate the etiological relationship between Epstein-Barr virus (EBV) infection and atherosclerosis.
• To substantiate the hypothesis of a cause-sequel link between chronic EBV infection (infectious mononucleosis) and the development of atherosclerosis.
• To explore novel diagnostic and therapeutic approaches for atherosclerosis based on its potential viral etiology.

Summary:

• This study synthesizes clinical, epidemiological, and serological data, alongside literature reviews, to propose a causal link between chronic persistent Epstein-Barr herpes virus infection (infectious mononucleosis) and atherosclerosis.
• Detailed findings support the identification of the etiologic agent responsible for atherosclerosis.
• The research highlights the potential for new diagnostic, treatment, and prophylactic strategies targeting the viral cause of atherosclerosis.

Impact:

• Establishes a potential viral etiology for atherosclerosis, shifting current understanding of cardiovascular disease.
• Opens avenues for developing targeted antiviral therapies for atherosclerosis.
• Facilitates the design of novel diagnostic tools to identify individuals at risk due to EBV infection.
• Provides a foundation for new preventative measures against atherosclerosis by addressing chronic viral infections.